24-hour symptom control with adjunctive ropinirole prolonged release in patients with advanced Parkinson's disease (PD) and significant nocturnal symptoms

被引：0

作者：

Stocchi, F. ^{[1
]}

Cooper, J. ^{[2
]}

Rolfe, K. ^{[3
]}

Lipschitz, A. ^{[4
]}

Chaudhuri, K. R. ^{[5
,6
]}

机构：

[1] IRCCS, Dept Neurol, Rome, Italy

[2] GlaxoSmithKline Inc, Brentford, England

[3] GlaxoSmithKline Inc, Uxbridge, Middx, England

[4] GlaxoSmithKline Inc, King Of Prussia, PA USA

[5] Kings Coll London, Univ Hosp Lewisham, Kings Coll Hosp, Natl Parkinson Fdn Ctr Excellence, London WC2R 2LS, England

[6] Inst Psychiat, London, England

来源：

EUROPEAN JOURNAL OF NEUROLOGY | 2010年 / 17卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：116 / 116

页数：1

共 50 条

[1] Adjunctive ropinirole 24-hour prolonged release compared with ropinirole immediate release in patients with advanced Parkinson's disease (PD): the PREPARED study
Stocchi, F.
Hunter, B.
Giorgi, L.
Schapira, A. H. V.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 134 - 134
[2] Comparison of adjunctive ropinirole 24-hour prolonged release and ropinirole immediate release in patients with advanced Parkinson's disease: The PREPARED study
Stocchi, F.
Huter, B.
Giorgi, L.
Schapira, A. H. V.
[J]. MOVEMENT DISORDERS, 2008, 23 (01) : S215 - S216
[3] 24-Hour Symptom Control with Ropinirole Prolonged Release in Patients with Advanced Parkinson's Disease Not Optimally Controlled with L-Dopa
Stocchi, Fabrizio
Rolfe, Katie
Cooper, James
Lipschitz, Alan
[J]. NEUROLOGY, 2010, 74 (09) : A393 - A394
[4] Effects of ropinirole prolonged release on sleep duration in patients with advanced Parkinson's disease (PD) with significant nocturnal symptoms
Martinez-Martin, P.
Reichmann, H.
Cooper, J.
Rolfe, K.
Lipschitz, A.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 387 - 387
[5] Adjunctive ropinirole 24-hour prolonged release reduces "Off" time and improves the cardinal symptoms of tremor, rigidity, and bradykinesia in patients with advanced Parkinson's disease (PD)
Pahwa, R.
Stover, N.
Earl, N.
[J]. MOVEMENT DISORDERS, 2007, 22 (12) : X - X
[6] On evaluation of symptom control in patients with advanced PD receiving adjunctive ropinirole 24-hour prolonged release versus ropinirole immediate release: results from the PREPARED study
Stocchi, F.
Hunter, B.
Giorgi, L.
Schapira, A. H. V.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 134 - 134
[7] Ropinirole 24-hour prolonged release improves mood and quality of life in patients with advanced Parkinson's disease as adjunctive therapy
Stocchi, F.
Isaacson, S.
Edin, H.
[J]. PARKINSONISM & RELATED DISORDERS, 2007, 13 : S109 - S109
[8] Safety and tolerability of ropinirole 24-hour prolonged release in patients with early and advanced Parkinson's disease
Stocchi, F.
Hersh, B. P.
Earl, N. L.
Scott, B. L.
[J]. MOVEMENT DISORDERS, 2006, 21 : S572 - S572
[9] Safety and tolerability of ropinirole 24-hour prolonged release in patients with early and advanced Parkinson's disease
Stocchi, F.
Hersh, B. P.
Giorgi, L.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 76 - 76
[10] Comparison of adjunctive ropinirole 24-hour prolonged release and ropinirole immediate release in patients with advanced Parkinson's disease: A per-protocol analysis of the PREPARED study
Schapira, A. H. V.
Stocchi, F.
Hunter, B.
Giorgi, L.
[J]. MOVEMENT DISORDERS, 2008, 23 (01) : S196 - S197

← 1 2 3 4 5 →